Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016;387(10021):882–93. https://doi.org/10.1016/S0140-6736(15)00067-7.
Dayer MJ, Jones S, Prendergast B, Baddour LM, Lockhart PB, Thornhill MH. Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis. Lancet. 2015;385(9974):1219–28. https://doi.org/10.1016/S0140-6736(14)62007-9.
Olmos C, Vilacosta I, Fernandez-Perez C, Bernal JL, Ferrera C, Garcia-Arribas D, et al. The evolving nature of infective endocarditis in Spain: a population-based study (2003 to 2014). J Am Coll Cardiol. 2017;70(22):2795–804. https://doi.org/10.1016/j.jacc.2017.10.005.
Toyoda N, Chikwe J, Itagaki S, Gelijns AC, Adams DH, Egorova NN. Trends in infective endocarditis in California and New York State, 1998-2013. JAMA. 2017;317(16):1652–60. https://doi.org/10.1001/jama.2017.4287.
Article PubMed PubMed Central Google Scholar
Shah ASV, McAllister DA, Gallacher P, Astengo F, Rodriguez Perez JA, Hall J, et al. Incidence, microbiology, and outcomes in patients hospitalized with infective endocarditis. Circulation. 2020;141(25):2067–77. https://doi.org/10.1161/CIRCULATIONAHA.119.044913.
Article PubMed PubMed Central Google Scholar
Iung B, Duval X. Infective endocarditis: innovations in the management of an old disease. Nat Rev Cardiol. 2019;16(10):623–35. https://doi.org/10.1038/s41569-019-0215-0.
Kumar A, Anstey C, Tesar P, Shekar K. Risk factors for mortality in patients undergoing cardiothoracic surgery for infective endocarditis. Ann Thorac Surg. 2019;108(4):1101–6. https://doi.org/10.1016/j.athoracsur.2019.05.029.
Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019;40(39):3222–32. https://doi.org/10.1093/eurheartj/ehz620.
Article CAS PubMed Google Scholar
Ren Z, Mo X, Chen H, Peng J. A changing profile of infective endocarditis at a tertiary hospital in China: a retrospective study from 2001 to 2018. BMC Infect Dis. 2019;19(1):945. https://doi.org/10.1186/s12879-019-4609-8.
Article PubMed PubMed Central Google Scholar
De Feo M, Cotrufo M, Carozza A, De Santo LS, Amendolara F, Giordano S, et al. The need for a specific risk prediction system in native valve infective endocarditis surgery. Sci World J. 2012;2012:307571. https://doi.org/10.1100/2012/307571.
Gaca JG, Sheng S, Daneshmand MA, O'Brien S, Rankin JS, Brennan JM, et al. Outcomes for endocarditis surgery in North America: a simplified risk scoring system. J Thorac Cardiovasc Surg. 2011;141(1):98–106. https://doi.org/10.1016/j.jtcvs.2010.09.016.
Chee QZ, Tan YQ, Ngiam JN, Win MT, Shen X, Choo JN, et al. The SHARPEN clinical risk score predicts mortality in patients with infective endocarditis: an 11-year study. Int J Cardiol. 2015;191:273–6. https://doi.org/10.1016/j.ijcard.2015.04.236.
Park LP, Chu VH, Peterson G, Skoutelis A, Lejko-Zupa T, Bouza E, et al. Validated risk score for predicting 6-month mortality in infective endocarditis. J Am Heart Assoc. 2016;5(4):e003016. https://doi.org/10.1161/JAHA.115.003016.
Article PubMed PubMed Central Google Scholar
Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075–128. https://doi.org/10.1093/eurheartj/ehv319.
Varela L, Lopez-Menendez J, Redondo A, Fajardo ER, Miguelena J, Centella T, et al. Mortality risk prediction in infective endocarditis surgery: reliability analysis of specific scores. Eur J Cardiothorac Surg. 2018;53(5):1049–54. https://doi.org/10.1093/ejcts/ezx428.
Rizzo V, Salmasi MY, Sabetai M, Primus C, Sandoe J, Lewis M, Woldman S, Athanasiou T. Infective endocarditis: do we have an effective risk score model? A systematic review. Front Cardiovasc Med. 2023;10:1093363. https://doi.org/10.3389/fcvm.2023.1093363.
Article PubMed PubMed Central Google Scholar
Hurrell H, Roberts-Thomson R, Prendergast BD. Non-infective endocarditis. Heart. 2020;106(13):1023–9. https://doi.org/10.1136/heartjnl-2019-315204.
Article CAS PubMed Google Scholar
Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633–8. https://doi.org/10.1086/313753.
Article CAS PubMed Google Scholar
Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23(7):685–713. https://doi.org/10.1016/j.echo.2010.05.010.
Garcia-Granja PE, Lopez J, Vilacosta I, Sarria C, Dominguez F, Ladron R, et al. Predictive model of in-hospital mortality in left-sided infective endocarditis. Rev Esp Cardiol (Engl Ed). 2020;73(11):902–9. https://doi.org/10.1016/j.rec.2019.11.003.
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12. https://doi.org/10.7326/0003-4819-150-9-200905050-00006.
Article PubMed PubMed Central Google Scholar
DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–45.
Article CAS PubMed Google Scholar
Chu VH, Park LP, Athan E, Delahaye F, Freiberger T, Lamas C, et al. Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis. Circulation. 2015;131(2):131–40. https://doi.org/10.1161/CIRCULATIONAHA.114.012461.
Costa MA, Wollmann DR Jr, Campos AC, Cunha CL, Carvalho RG, Andrade DF, et al. Risk index for death by infective endocarditis: a multivariate logistic model. Rev Bras Cir Cardiovasc. 2007;22(2):192–200. https://doi.org/10.1590/s0102-76382007000200007.
Martinez-Selles M, Munoz P, Arnaiz A, Moreno M, Galvez J, Rodriguez-Roda J, et al. Valve surgery in active infective endocarditis: a simple score to predict in-hospital prognosis. Int J Cardiol. 2014;175(1):133–7. https://doi.org/10.1016/j.ijcard.2014.04.266.
Di Mauro M, Dato GMA, Barili F, Gelsomino S, Sante P, Corte AD, et al. A predictive model for early mortality after surgical treatment of heart valve or prosthesis infective endocarditis. The EndoSCORE. Int J Cardiol. 2017;241:97–102. https://doi.org/10.1016/j.ijcard.2017.03.148.
Olmos C, Vilacosta I, Habib G, Maroto L, Fernandez C, Lopez J, et al. Risk score for cardiac surgery in active left-sided infective endocarditis. Heart. 2017;103(18):1435–42. https://doi.org/10.1136/heartjnl-2016-311093.
Gatti G, Perrotti A, Obadia JF, Duval X, Iung B, Alla F, et al. Simple scoring system to predict in-hospital mortality after surgery for infective endocarditis. J Am Heart Assoc. 2017;6(7) https://doi.org/10.1161/JAHA.116.004806.
Gatti G, Benussi B, Gripshi F, Della Mattia A, Proclemer A, Cannata A, et al. A risk factor analysis for in-hospital mortality after surgery for infective endocarditis and a proposal of a new predictive scoring system. Infection. 2017;45(4):413–23. https://doi.org/10.1007/s15010-016-0977-9.
Varela Barca L, Fernandez-Felix BM, Navas Elorza E, Mestres CA, Munoz P, Cuerpo-Caballero G, et al. Prognostic assessment of valvular surgery in active infective endocarditis: multicentric nationwide validation of a new score developed from a meta-analysis. Eur J Cardiothorac Surg. 2020;57(4):724–31. https://doi.org/10.1093/ejcts/ezz328.
Gatti G, Sponga S, Peghin M, Givone F, Ferrara V, Benussi B, et al. Risk scores and surgery for infective endocarditis: in search of a good predictive score. Scand Cardiovasc J. 2019;53(3):117–24. https://doi.org/10.1080/14017431.2019.1610188.
Wang A, Gaca JG, Chu VH. Management considerations in infective endocarditis: a review. JAMA. 2018;320(1):72–83. https://doi.org/10.1001/jama.2018.7596.
El Hadi H, Di Vincenzo A, Vettor R, Rossato M. Relationship between heart disease and liver disease: a two-way street. Cells. 2020;9(3). https://doi.org/10.3390/cells9030567.
Xanthopoulos A, Starling RC, Kitai T, Triposkiadis F. Heart failure and liver disease: cardiohepatic interactions. JACC Heart Fail. 2019;7(2):87–97. https://doi.org/10.1016/j.jchf.2018.10.007.
Delemos AS, Friedman LS. Systemic causes of cholestasis. Clin Liver Dis. 2013;17(2):301–17. https://doi.org/10.1016/j.cld.2012.11.001.
Article PubMed PubMed Central Google Scholar
Cuervo G, Escrihuela-Vidal F, Gudiol C, Carratala J. Current challenges in the management of infective endocarditis. Front Med (Lausanne). 2021;8:641243. https://doi.org/10.3389/fmed.2021.641243.
Comments (0)